Titan Bio-Tech share news, announcements and annual reports
BSE: 524717Chemicals & PetrochemicalsSmall Cap
Titan Bio-Tech Ltd. · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1994
Last close ₹352.00up ₹27.15 (8.36%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹324.85.
28 Oct: open ₹357.30, high ₹357.30, low ₹339.90
52-week range of traded prices to 28 Oct 2026
₹137.12Low, 9 Dec 2025₹444.52High, 7 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,818 Cr1,287th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 53.66
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 10.01
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.11%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 91,662
Titan Bio-Tech disputes and clarifications
14 filed, newest first.
Jul 2025
Oct 2024
22 Oct · Legal
21 Oct · Legal
Exchange has sought clarification from Titan Biotech Ltd on October 21, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Jan 2024
15 Jan · Legal
12 Jan · Legal
Exchange has sought clarification from Titan Biotech Ltd on January 11, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Apr 2021
28 Apr · Legal
27 Apr · Legal
Exchange has sought clarification from Titan Biotech Ltd on April 27, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
May 2020
13 May · Legal
Exchange has sought clarification from Titan Biotech Ltd on May 13, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Mar 2020
26 Mar · Legal
Exchange has sought clarification from Titan Biotech Ltd on 26th March, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Feb 2020
27 Feb · Legal
Exchange has sought clarification from Titan Biotech Ltd on 27th February, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Sep 2019
14 Sep · Legal
Exchange has sought clarification from Titan Biotech Ltd on 13 September 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant ....